These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22957996)

  • 1. Genetic determinants of breast cancer risk: a review of current literature and issues pertaining to clinical application.
    Njiaju UO; Olopade OI
    Breast J; 2012 Sep; 18(5):436-42. PubMed ID: 22957996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance.
    Skol AD; Sasaki MM; Onel K
    Breast Cancer Res; 2016 Oct; 18(1):99. PubMed ID: 27716388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition.
    Afghahi A; Kurian AW
    Curr Treat Options Oncol; 2017 May; 18(5):27. PubMed ID: 28439798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Other" breast cancer susceptibility genes: searching for more holy grail.
    Nathanson KL; Weber BL
    Hum Mol Genet; 2001 Apr; 10(7):715-20. PubMed ID: 11257104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new paradigm of genetic testing for hereditary breast/ovarian cancers.
    Kwong A; Chen JW; Shin VY
    Hong Kong Med J; 2016 Apr; 22(2):171-7. PubMed ID: 26980575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying breast cancer susceptibility genes - a review of the genetic background in familial breast cancer.
    Wendt C; Margolin S
    Acta Oncol; 2019 Feb; 58(2):135-146. PubMed ID: 30606073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
    Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE
    Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer gene discovery.
    Polyak K
    Expert Rev Mol Med; 2002 Aug; 4(18):1-18. PubMed ID: 14987381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited genetic susceptibility to breast cancer.
    Chang-Claude J
    IARC Sci Publ; 2001; 154():177-90. PubMed ID: 11220657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer susceptibility: current knowledge and implications for genetic counselling.
    Ripperger T; Gadzicki D; Meindl A; Schlegelberger B
    Eur J Hum Genet; 2009 Jun; 17(6):722-31. PubMed ID: 19092773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic risk of breast cancer.
    Nasir A; Shackelford RE; Anwar F; Yeatman TJ
    Minerva Endocrinol; 2009 Dec; 34(4):295-309. PubMed ID: 20046159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline DNA variations in breast cancer predisposition and prognosis: a systematic review of the literature.
    Sapkota Y
    Cytogenet Genome Res; 2014; 144(2):77-91. PubMed ID: 25401968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.
    Piccinin C; Panchal S; Watkins N; Kim RH
    Expert Rev Anticancer Ther; 2019 Sep; 19(9):787-801. PubMed ID: 31469018
    [No Abstract]   [Full Text] [Related]  

  • 15. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.
    Shattuck-Eidens D; Oliphant A; McClure M; McBride C; Gupte J; Rubano T; Pruss D; Tavtigian SV; Teng DH; Adey N; Staebell M; Gumpper K; Lundstrom R; Hulick M; Kelly M; Holmen J; Lingenfelter B; Manley S; Fujimura F; Luce M; Ward B; Cannon-Albright L; Steele L; Offit K; Thomas A
    JAMA; 1997 Oct; 278(15):1242-50. PubMed ID: 9333265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic predisposition to breast cancer.
    Skolnick MH; Cannon-Albright LA
    Cancer; 1992 Sep; 70(6 Suppl):1747-54. PubMed ID: 1516030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary breast cancer; Genetic penetrance and current status with BRCA.
    Mahdavi M; Nassiri M; Kooshyar MM; Vakili-Azghandi M; Avan A; Sandry R; Pillai S; Lam AK; Gopalan V
    J Cell Physiol; 2019 May; 234(5):5741-5750. PubMed ID: 30552672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary breast cancer: high risk genes, genetic testing and clinical implications.
    Hamann U
    Clin Lab; 2000; 46(9-10):447-61. PubMed ID: 11034530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.
    Borg A; Dørum A; Heimdal K; Maehle L; Hovig E; Møller P
    Dis Markers; 1999 Oct; 15(1-3):79-84. PubMed ID: 10595257
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.